"
Team:Amsterdam/safety/components
From 2012.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Team:Amsterdam/stylesheet}} | + | {{Team:Amsterdam/ernst/stylesheet}} |
| - | {{Team:Amsterdam/scripts}} | + | {{Team:Amsterdam/ernst/scripts}} |
| - | {{Team:Amsterdam/Header}} | + | {{Team:Amsterdam/ernst/Header}} |
| - | {{Team:Amsterdam/Sidebar1}} | + | {{Team:Amsterdam/ernst/Sidebar1}} |
| - | <div id=" | + | |
| + | <div id="content-area"> | ||
| + | <div id="sub-menu" class="content-block"> | ||
| + | |||
<h1>Overview of used components</h1> | <h1>Overview of used components</h1> | ||
| + | __TOC__ | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Plasmids</h2> | <h2>Plasmids</h2> | ||
| Line 15: | Line 22: | ||
pSB1AT3<br> | pSB1AT3<br> | ||
(GFP plasmid)<br><br> | (GFP plasmid)<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Vectors</h2> | <h2>Vectors</h2> | ||
| Line 22: | Line 32: | ||
(GFP?)<br> | (GFP?)<br> | ||
Ordered M.ScaI synthesized vector<br><br> | Ordered M.ScaI synthesized vector<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Chemicals</h2> | <h2>Chemicals</h2> | ||
| Line 30: | Line 43: | ||
Ampicilin<br> | Ampicilin<br> | ||
Kanamycin<br><br> | Kanamycin<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Substances</h2> | <h2>Substances</h2> | ||
| Line 35: | Line 51: | ||
AGAR<br> | AGAR<br> | ||
LB<br><br> | LB<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Bacteria</h2> | <h2>Bacteria</h2> | ||
DH5-alpha<br><br> | DH5-alpha<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Kits</h2> | <h2>Kits</h2> | ||
| Line 43: | Line 65: | ||
Qiagen Gel extraction<br> | Qiagen Gel extraction<br> | ||
Qiagen PCR purification<br><br> | Qiagen PCR purification<br><br> | ||
| + | |||
| + | </div> | ||
| + | <div id="sub-menu" class="content-block"> | ||
<h2>Methods</h2> | <h2>Methods</h2> | ||
| Line 49: | Line 74: | ||
Uva/VU and RIVM safety (GMO’s) | Uva/VU and RIVM safety (GMO’s) | ||
</div> | </div> | ||
| - | {{Team:Amsterdam/Foot}} | + | </div> |
| + | |||
| + | {{Team:Amsterdam/ernst/Foot}} | ||
Revision as of 11:20, 14 September 2012
